Intra-articular Treatment with Triamcinolone Hexacetonide Associated with Gold Nanoparticles Reduces Cartilage Degeneration in an Animal Model of Osteoarthritis
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
INTRODUCTION: The association between triamcinolone hexacetonide (TH) and gold nanoparticles (GNPs) represents a promising treatment due to the potential anti-inflammatory and antioxidant effects of these compounds. In this study, we evaluated the effects of intra-articular treatment of TH associated with GNPs in a mechanical model of osteoarthritis (OA).
METHODS: Fifty Wistar rats were divided into five groups: Sham; OA; OA+TH; OA+GNPs; OA+TH-GNPs. Both applications were performed 30 and 60 days after the model was induced. After 30 days of the last application, the animals were euthanized.
RESULTS: Only the combined treatment with TH and GNPs promoted a reduction in proinflammatory cytokines and an increase in anti-inflammatory cytokines. The OA+TH-GNPs group obtained a significant reduction in the production of oxidants and oxidative damage markers while an increase in antioxidants. Histologically, all treated groups showed results of a significant increase in cartilage thickness and chondrocyte count, the OA+TH-GNPs group had similar behavior to the group without osteoarthritis, with significantly smaller amounts of chondrocytes than the OA group.
CONCLUSION: The intra-articular use of TH associated with GNPs may be able to prevent the progression of the pathology and minimize joint degradation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Current drug targets - 24(2023), 3 vom: 14., Seite 287-296 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Dos Santos Haupenthal, Daniela Pacheco [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 16.03.2023 Date Revised 21.03.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1389450124666221212090319 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM350270201 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM350270201 | ||
003 | DE-627 | ||
005 | 20231226044628.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1389450124666221212090319 |2 doi | |
028 | 5 | 2 | |a pubmed24n1167.xml |
035 | |a (DE-627)NLM350270201 | ||
035 | |a (NLM)36515017 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Dos Santos Haupenthal, Daniela Pacheco |e verfasserin |4 aut | |
245 | 1 | 0 | |a Intra-articular Treatment with Triamcinolone Hexacetonide Associated with Gold Nanoparticles Reduces Cartilage Degeneration in an Animal Model of Osteoarthritis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.03.2023 | ||
500 | |a Date Revised 21.03.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a INTRODUCTION: The association between triamcinolone hexacetonide (TH) and gold nanoparticles (GNPs) represents a promising treatment due to the potential anti-inflammatory and antioxidant effects of these compounds. In this study, we evaluated the effects of intra-articular treatment of TH associated with GNPs in a mechanical model of osteoarthritis (OA) | ||
520 | |a METHODS: Fifty Wistar rats were divided into five groups: Sham; OA; OA+TH; OA+GNPs; OA+TH-GNPs. Both applications were performed 30 and 60 days after the model was induced. After 30 days of the last application, the animals were euthanized | ||
520 | |a RESULTS: Only the combined treatment with TH and GNPs promoted a reduction in proinflammatory cytokines and an increase in anti-inflammatory cytokines. The OA+TH-GNPs group obtained a significant reduction in the production of oxidants and oxidative damage markers while an increase in antioxidants. Histologically, all treated groups showed results of a significant increase in cartilage thickness and chondrocyte count, the OA+TH-GNPs group had similar behavior to the group without osteoarthritis, with significantly smaller amounts of chondrocytes than the OA group | ||
520 | |a CONCLUSION: The intra-articular use of TH associated with GNPs may be able to prevent the progression of the pathology and minimize joint degradation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Osteoarthritis | |
650 | 4 | |a antioxidants | |
650 | 4 | |a gold nanoparticles | |
650 | 4 | |a inflammation | |
650 | 4 | |a oxidative stress | |
650 | 4 | |a triamcinolone hexacetonide | |
650 | 7 | |a triamcinolone hexacetonide |2 NLM | |
650 | 7 | |a I7GT1U99Y9 |2 NLM | |
650 | 7 | |a Gold |2 NLM | |
650 | 7 | |a 7440-57-5 |2 NLM | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
650 | 7 | |a Cytokines |2 NLM | |
700 | 1 | |a Resmini, Marcus Barg |e verfasserin |4 aut | |
700 | 1 | |a Da Silva, Leandro Almeida |e verfasserin |4 aut | |
700 | 1 | |a Colares, Mateus Cardoso |e verfasserin |4 aut | |
700 | 1 | |a de Roch Casagrande, Laura |e verfasserin |4 aut | |
700 | 1 | |a Milanez Venturini, Ligia |e verfasserin |4 aut | |
700 | 1 | |a de Andrade, Thiago Antônio Moretti |e verfasserin |4 aut | |
700 | 1 | |a do Bomfim, Fernando Russo Costa |e verfasserin |4 aut | |
700 | 1 | |a Thirupathi, Anand |e verfasserin |4 aut | |
700 | 1 | |a Emilio Feuser, Paulo |e verfasserin |4 aut | |
700 | 1 | |a Dal Pizzol, Felipe |e verfasserin |4 aut | |
700 | 1 | |a Silveira, Paulo Cesar Lock |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current drug targets |d 2000 |g 24(2023), 3 vom: 14., Seite 287-296 |w (DE-627)NLM113669291 |x 1873-5592 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2023 |g number:3 |g day:14 |g pages:287-296 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389450124666221212090319 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2023 |e 3 |b 14 |h 287-296 |